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Aspirin interacts in vitro with human low-density lipoprotein (LDL), which results in a decrease in free 
amino groups of apolipoprotein B and an increase of electrophoretic mobility of the particle. The aspirin- 
treated LDL was less efficiently recognized than native LDL by the apo B/E receptor of fibroblasts. These 
results suggest hat aspirin in long-term treatment could influence the LDL-receptor pathway. However, 
aspirin-treated LDL did not bind to the scavenger receptor of macrophages. 
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1. INTRODUCTION 
It has been reported that human serum albumin 
and other serum proteins such as im- 
m.unoglobulins, transferrin and fibrinogen are 
altered after exposure to therapeutic concentra- 
tions of acetylsalicylic acid (ASA, aspirin), either 
in vitro or in vivo [1,2]. These alterations arise 
from acetylation of lysine residues [3]. It is also 
known that chemical modification such as acetyla- 
tion of the lysine residues of low density lipopro- 
teins (LDL) decreases their binding, internalization 
and degradation by fibroblasts [4]. The catabolism 
of the modified LDL is shifted to the ‘scavenger 
receptors’ of macrophages, which accumulate high 
amounts of cholesteryl esters; this process results 
in foam cell formation [5,6] and subsequent 
development of atherosclerotic lesions. 
The aim of the present work was to study the ef- 
fects of therapeutic doses of ASA upon LDL and 
to determine to what extent ASA may alter LDL 
binding, internalization and degradation by 
cultured human fibroblasts. As altered LDL can be 
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recognized by macrophages when the negative net 
charge of the particle is sufficiently increased [7], 
we also tested ASA-LDL on 5774 mouse 
macrophages . 
2. MATERIALS AND METHODS 
2.1. Materials 
Na’? (13-17 Ci/mg) was from Amersham 
(England) and Dulbecco’s modified minimum 
essential medium (MEM) with Earle’s salts and 
fetal calf serum from Gibco (Grand Island, NY). 
MRCS human fetal lung fibroblasts were pur- 
chased from BioMCrieux, France and 5774 mouse 
macrophages from the American Type Culture 
Collection (Rockville, MD). Ultroser G was from 
Industries Biologiques Franqaises (France). Silica 
gel plates F 1500 were from Schleicher and Schuell 
(Dassel, FRG). 
2.2. Ceil culture 
Cells were cultured in 35 mm Nunc petri dishes 
containing 2 ml Dulbecco’s MEM medium sup- 
plemented with 20 mM Hepes buffer (pH 7.4), 
100 U/ml penicillin, 100 pg/ml streptomycin and 
10% (v/v) fetal calf serum, at 37°C in a humidified 
atmosphere of 5% COZ. Experiments were per- 
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formed on confluent cells, approx. 7 days after ASA-LDL, AC-LDL or native LDL. Results are 
seeding. expressed as percentages of controls. 
2.3. LDL preparation and labeling 
LDL was prepared from normal human serum 
by 3-step ultracentrifugation at 105000 x g in a 
Beckman L5-50 instrument, according to Have1 et 
al. [8]. The LDL was taken as the 1.024-1.050 
fraction. Labeling was performed as described by 
Bilheimer et al. [9]. Protein determination was 
done according to Lowry et al. [lo]. The specific 
activity was about 250-350 dpm/ng LDL protein, 
and free [‘*‘I]iodine in the preparation was always 
below 2.5%. 
3. RESULTS AND DISCUSSION 
ASA-modified LDL submitted to Sephadex 
G-75 chromatography eluted in a peak at the void 
volume (coincident with Blue dextran 2000) and 
presented a small shoulder. A similar profile, in- 
dicating slight heterogeneity of particles, was 
observed for native LDL and AC-LDL (not 
shown). For all experiments, only fractions cor- 
responding to the major peak were used. 
2.4. LDL modification and characterization 
Derivatization of the lysine residues as assessed 
by TNBS assay was about 9% in ASA-LDL and 
about 53% in AC-LDL. 
Acetylated LDL (AC-LDL) was prepared using 
the technique of Basu et al. [ 111. For modification 
by ASA (ASA-LDL), LDL (1.5 mg) was incubated 
with 3 mg ASA in 0.1 M phosphate buffer (pH 
7.4) at 37°C for 24 h, according to Hawkins et al. 
[2]. After incubation, the LDL was extensively 
dialysed against 0.1 M phosphate buffer (pH 7,4). 
The product was chromatographed on Sephadex 
G-75, using 0.025 M Tris, 0.0001% EDTA (pH 
7.6) as elution buffer. The extent of derivatization 
of lysine residues in modified LDL was estimated 
by the calorimetric trinitrobenzenesulfonic acid 
(TNBS) assay for primary amines [12], using HCl- 
lysine as standard. Electrophoresis was performed 
on universal electrophoresis agarose film (Corning 
Chemicals, Palo Alto, CA) and stained with oil red 
0. LDL and the modified products were subjected 
to SDS-polyacrylamide gel electrophoresis (Weber 
and Osborn) in 4% flat gels. Double immunodiffu- 
sion using a rabbit antiserum to LDL was perform- 
ed under the conditions in [ 131. 
Fig. la shows that the electrophoretic mobility of 
ASA-LDL was increased by 2.4 +- 1.6 mm (21 = 9) 
as compared to native LDL. This indicates a higher 
negative net charge of the particle. In comparison, 
AC-LDL mobility was increased by 23 f 2.5 mm 
(n = 10). 
Polyacrylamide gel electrophoresis did not show 
any alteration in ASA-LDL as compared to LDL, 
whereas AC-LDL presented some discrete aggrega- 
tion. Upon immunodiffusion, when compared to 
native LDL, ASA-LDL and AC-LDL showed pat- 
terns of identity and partial identity, respectively 
(fig. lb). This indicates a larger modification of the 
antigenic sites in AC-LDL than in ASA-LDL. 
Competition studies performed on cultured 
2.5. LDL binding, internalization and 
degradation by cultured human fibroblasts 
Binding, internalization and degradation of ‘*‘I- 
LDL by human fibroblasts and 1251-AC-LDL by 
5774 mouse macrophages were studied as de- 
scribed in [14]. For maximal expression of LDL 
receptors, fibroblasts were preincubated for 24 h 
in medium devoid of lipoproteins (Dulbecco’s 
MEM + 2% Ultroser G). Cells were incubated in 
the presence of 10 rg/ml ‘*‘I-LDL (fibroblasts) or 
‘*‘I-AC-LDL (macrophages), in the absence or 
presence of increasing concentrations of unlabeled 
Fig.1. (a) Agarose gel electrophoresis of native and 
modified LDL: 1, native LDL; 2, ASA-LDL; 3, AC- 
LDL. The arrow indicates the origin. (b) 
Immunodiffusion pattern of LDL, AC-LDL and ASA- 
LDL reacting with an antiserum to LDL. Central well, 
antiserum to LDL. Peripheral wells: 1, 3, LDL; 2, AC- 
LDL; 4, ASA-LDL. Soudan black staining. 
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Fig.2. Competition studies with ASA-modified LDL (v) 
and native LDL (m) on 12’I-LDL binding (a), uptake (b) 
and degradation (c) by cultured human fibroblasts. Cells 
were preincubated for 24 h in medium supplemented 
with 2% Ultroser G for induction of LDL receptors. 
“‘1-LDL binding, uptake and degradation were 
determined as described in section 2 in the absence or 
presence of the indicated amount of ASA-LDL or native 
LDL. Results, expressed in ng “‘1-LDL/mg cell 
proteins, have been converted into percentages: 100% = 
125 f 26 ng LDL bound/mg; 646 + 76 ng LDL 
internalized/mg and 1247 + 182 ng LDL degraded/mg. 
Means of 3 experimental values. 
fact that the decreases in LDL binding, uptake and 
degradation were of the same order of magnitude 
suggests that decreased uptake and degradation 
Table 1 
Competition studies with ASA-LDL and native LDL on ‘251-AC-LDL 
uptake and degradation by the macrophage cell line 5774 
Addition Binding Uptake Degradation 
None 80 + 15 (100%) 642 f 75 (100%) 956 f 114 (lOOa) 
AC-LDL 34 * 4 (43%) 257 f 31 (40%) 335 + 31 (35%) 
ASA-LDL 78 + 11 (98%) 625 f 66 (97%) 967 f 109 (101%) 
12’I-LDL uptake and degradation were determined using 10 pg/ml ‘2’I-AC- 
LDL in the absence or presence of lObg/ml unlabeled AC-LDL or ASA- 
LDL. Results are expressed as ng ‘251-AC-LDL/mg protein. Means of 3 
determinations f SD 
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were most likely secondary to the decrease in LDL 
binding. Thus, the ability of ASA-LDL to bind to 
the apo B/E receptor of fibroblasts was reduced, 
and this is probably due to the increase in negative 
net charge of LDL by ASA modification. To deter- 
mine whether ASA-LDL is recognized by the 
scavenger eceptor of macrophages, we used the 
mouse macrophage cell line 5774 for competition 
studies with rz51-AC-LDL. The data in table 1 
show that ASA-LDL did not compete significantly 
with AC-LDL. This suggests that LDL modifica- 
tion by ASA did not induce sufficient alterations in 
the particle to allow its recognition by the AC-LDL 
receptor of macrophages. 
As is the case for other serum proteins, ASA 
probably induces acetylation of some lysine 
residues of apolipoprotein B, as suggested by the 
decrease in free amino groups observed with the 
TNBS assay. Previous studies have demonstrated a
relationship between the number of modified 
lysine residues and the decreased affinity for the 
apo B/E receptor of fibroblasts [5]. In the case of 
ASA-LDL, a discrete alteration of the LDL parti- 
cle (less than 10% of the lysine residues), undetec- 
table by immunodiffusion studies, is sufficient to 
induce a significant alteration of the recognition by 
the fibroblast LDL receptor. However, this 
modification is insufficient to allow binding to the 
scavenger eceptor of macrophages. 
It should be noted that in the experiments 
described, the dose of ASA used was close to those 
used therapeutically [2]. Thus, similar alterations 
in LDL structure and metabolism may occur in 
vivo in patients treated with ASA. As ASA is wide- 
ly utilized, the possibility of perturbations in LDL 
catabolism by the apo B/E receptor pathway 
should be taken into account, especially in long- 
term treatment. Finally, it can be noted that 
binding studies provide a sensitive test for the 
detection of weak alterations in LDL particles. 
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